CryoMatrix
Commercial- Indications
- Orthopedic applications
Company intelligence / Profile preview
Skye Biologics develops regenerative therapies using proprietary BioECM® technology to preserve the extracellular matrix in human placental/amniotic tissues. Their commercialized allograft products are used in orthopedics, wound care, sports medicine, and surgical specialties. The company claims hundreds of thousands of patients have been treated with their products in the US. They are advancing a pipeline of next-generation regenerative biological therapies targeting high-unmet medical needs across musculoskeletal and internal tissue repair.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Skye Biologics.